An Efficacy and Safety Study for JNS024ER (Tapentadol ER) in Chronic Pain Patients Due to Painful Diabetic Peripheral Neuropathy or Postherpetic Neuralgia

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Janssen Pharmaceutical K.K.

ClinicalTrials.gov Identifier:

NCT01124617

First received: April 22, 2010

Last updated: October 27, 2012

Last verified: October 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	April 2011
Primary Completion Date:	April 2011 (Final data collection date for primary outcome measure)